BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Oct 26, 2015
Clinical News

MK-3682: Interim Phase IIa data

BioCentury | Nov 17, 2014
Clinical News

Grazoprevir/elbasvir: Interim Phase II data

BioCentury | Nov 11, 2014
Clinical News

Merck reports HCV triple-combo results

BioCentury | Jun 16, 2014
Company News

Idenix, Merck deal

BioCentury | Jun 16, 2014
Strategy

Nucleotide arms race

Idenix nucleotide analog fills Merck gap in race for pan-genotype HCV regimen
BioCentury | Jun 10, 2014
Top Story

Merck to acquire Idenix for $3.9B

BioCentury | Apr 14, 2014
Clinical News

IDX21437: Phase I/II data

BioCentury | Apr 14, 2014
Finance

Highlights of weekly biotech stock moves

Regulatory, clinical and other milestones
BioCentury | Apr 8, 2014
Clinical News

Idenix reports data for IDX21437

BioCentury | Apr 7, 2014
Clinical News

Idenix preclinical data

Items per page:
1 - 10 of 11